Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
| Metric | DXCM | GILD |
|---|
| Close | 87.34 | 147.68 |
| Market Cap | $33.0B | $183B |
| 1M | −1.60% | +6.31% |
| P/E (TTM) | 31.8 | — |
| Forward P/E | 26.1 | 25.3 |
| P/E 5-Yr Percentile | 10 | — |
| P/S | 6.4 | 6.0 |
| P/B | 12.1 | 15.3 |
| Dividend Yield | — | 3.98% |
| Latest Quarter Revenue | $1.3B | $7.8B |
| Revenue YoY | +13.1% | +10.2% |
| Gross Margin | 63.4% | 79.8% |
| Latest Quarter EPS | 0.64 | -8.45 |
| Avg Post-Earnings Move | ±9.4% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.52% | 3.01% |
| 90-Day Net Insider Buying | −$8.4M | −$15.4M |
DXCM · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
